The FDA has expanded the indication for Toujeo (insulin glargine; Sanofi) 300 Units/mL to include treatment of pediatric patients aged ≥6 years with diabetes mellitus. The Food and Drug Administration ...

* CHMP adopts positive opinion for expanded indication for Toujeo in children and adolescents (aged 6 to 17 years) with diabetes The trial, EDITION JUNIOR, is the first randomized, controlled trial ...

Sanofi (Euronext: SAN; NYSE: SNY) announced today that it received FDA approval for its Toujeo Max SoloStar insulin pen, the highest capacity long-acting insulin pen that will be available on the ...

Significant results from an international phase 3 study, EDITION, resulted in the approval of Toujeo in treating patients with type 1 as well as type 2 diabetes. Sanofi announced today that the FDA ...

PARIS (Reuters) - French drugmaker Sanofi plans to launch its new Toujeo insulin for diabetics in the United States on Monday, according to a source familiar with the matter. Toujeo was approved for ...

Sanofi said it has found adults with type 2 diabetes treated with its Toujeo® insulin injection experienced a consistently lower rate of confirmed or severe hypoglycemia both at night and at any time ...

The FINANCIAL — Sanofi announced on February 26 that the U.S. Food and Drug Administration (FDA) approved Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL), a once-daily long-acting basal ...

The FINANCIAL — Sanofi announced on April 28 that the European Commission has granted marketing authorization in Europe for Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL), a ...

Fact checked by Jennifer Klump Key Takeaways Insulin costs have declined over the past two years, and additional price cuts ...

The head-to-head comparison of four classes of medications assessed multiple metabolic, cardiovascular (CV), and safety outcomes for sulfonylurea glimepiride (Amaryl), the DPP-4 inhibitor sitagliptin ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

ENGAGE AF-TIMI: Insulin Linked to Greater Risk for Stroke, CV Death, Bleeding In a subanalysis, patients with diabetes treated with insulin were at higher risk for these outcomes compared with those ...